Literature DB >> 7603137

Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

A J Mocroft1, M A Johnson, C A Sabin, M Lipman, J Elford, V Emery, J Morcinek, M Youle, G Janossy, C A Lee.   

Abstract

Although there are wide differences in prognosis between patients with AIDS they are often thought of as a single homogeneous group. We think a simple staging system that accounts for important prognostic factors including type and number of AIDS diseases and the CD4 lymphocyte count is required. We followed 363 AIDS patients at the Royal Free Hospital and reported the occurrence of 680 AIDS-defining diseases (ADDs). We measured CD4 counts at approximately monthly intervals. Severity of AIDS diseases was defined a priori on the basis of survival in the AIDS in Europe study of 6578 AIDS patients: mild-oesophageal candidiasis, Kaposis sarcoma (cutaneous), Pneumocystis carinii pneumonia, extrapulmonary tuberculosis; severe-all other ADDs except lymphoma; very severe-lymphoma. The risk of death increased by 15% (p = 0.08) for each mild condition experienced, by 89% (p < 0.0001) for each new severe condition and by 535% (p < 0.0001) when a lymphoma developed. Estimates from the Cox model were used to derive a score reflecting the risk of death. Patient experience was divided into three categories. Patients in AIDS Grade I had an average death rate of one per 10.1 years, compared with one per 2.8 years in AIDS Grade II and one per 1.1 years in AIDS Grade III. Similar rates were seen in an independent validation study on 1230 AIDS patients at different hospital. Our grading system should be useful for patient management, clinical trial design, surveillance, and resource management.

Entities:  

Mesh:

Year:  1995        PMID: 7603137     DOI: 10.1016/s0140-6736(95)92649-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Ups and downs--and ups in the antiviral therapy of HIV infection.

Authors:  I V Weller; I Williams
Journal:  Genitourin Med       Date:  1996-02

2.  Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.

Authors:  R J Hillman; E J Beck; S Mandalia; H Satterthwaite; P A Rogers; G E Forster; B T Goh
Journal:  Genitourin Med       Date:  1997-02

3.  Annotation: wanted--a simple and meaningful HIV staging system.

Authors:  W el-Sadr; J D Neaton
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

4.  Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults.

Authors:  Hyun J Lim; Alphonse Okwera; Harriet Mayanja-Kizza; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  HIV Clin Trials       Date:  2006 Jul-Aug

5.  Validity and reliability of the Italian translation of the MOS-HIV health survey in persons with AIDS.

Authors:  Patrizia Schifano; Piero Borgia; Albert W Wu; Teresa Spadea; Giuseppe Milanese; Carlo A Perucci
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

6.  Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.

Authors:  Amy C Justice; K A McGinnis; M Skanderson; C C Chang; C L Gibert; M B Goetz; D Rimland; M C Rodriguez-Barradas; K K Oursler; S T Brown; R S Braithwaite; M May; K E Covinsky; M S Roberts; S L Fultz; K J Bryant
Journal:  HIV Med       Date:  2009-09-14       Impact factor: 3.180

7.  Reliability and validity of the Greek translation of the MOS-HIV health survey in HIV-infected individuals.

Authors:  Panagiota G Stasinopoulou; Chara Tzavara; Christine Dimitrakaki; Ourania Georgiou; Ioannis G Baraboutis; Athanasios Skoutelis; Vassilios Papastamipoulos; Yannis Tountas
Journal:  Qual Life Res       Date:  2010-03       Impact factor: 4.147

8.  Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.

Authors:  Amy C Justice; Sharada P Modur; Janet P Tate; Keri N Althoff; Lisa P Jacobson; Kelly A Gebo; Mari M Kitahata; Michael A Horberg; John T Brooks; Kate Buchacz; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Joseph Eron; James H Willig; Richard Moore; Gregory D Kirk; Ronald Bosch; Benigno Rodriguez; Robert S Hogg; Jennifer Thorne; James J Goedert; Marina Klein; John Gill; Steven Deeks; Timothy R Sterling; Kathryn Anastos; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

9.  Economic methods for measuring the quality of life associated with HIV infection.

Authors:  A M Bayoumi; D A Redelmeier
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 3.440

Review 10.  Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.

Authors:  Deepanwita Bose; Jean Gagnon; Yahia Chebloune
Journal:  Vet Sci       Date:  2015-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.